Formula & Concentration

NEUPRO (Rotigotine Transdermal System)

Manufacturer

UCB

Indications

NEUPRO is a dopamine agonist indicated for the treatment of:

  • Signs and symptoms of Parkinson’s disease
  • Moderate-to-severe primary Restless Legs Syndrome

Product Options

Package Size

NDC #

Presentation

Rotigotine transdermal system 1 mg/24 hrs

50474-0801-03

30 transdermal systems

Rotigotine transdermal system 2 mg/24 hrs

50474-0802-03

30 transdermal systems

Rotigotine transdermal system 3 mg/24 hrs

50474-0803-03

30 transdermal systems

Rotigotine transdermal system 4 mg/24 hrs

50474-0804-03

30 transdermal systems

Rotigotine transdermal system 6 mg/24 hrs

50474-0805-03

30 transdermal systems

Rotigotine transdermal system 8 mg/24 hrs

50474-0806-03

30 transdermal systems

Shelf Life and Storage

  • Store NEUPRO at 68ºF to 77ºF (20ºC to 25ºC).
  • Store NEUPRO in its original sealed pouch until use.
  • Do not store NEUPRO outside of the pouch.